| __timestamp | Dyne Therapeutics, Inc. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 1145000000 | 4167274 |
| Thursday, January 1, 2015 | 2028000000 | 5247851 |
| Friday, January 1, 2016 | 2281000000 | 4925118 |
| Sunday, January 1, 2017 | 2932000000 | 14930297 |
| Monday, January 1, 2018 | 24000 | 25371768 |
| Tuesday, January 1, 2019 | 271000 | 23921274 |
| Wednesday, January 1, 2020 | 700000 | 25338236 |
| Friday, January 1, 2021 | 1088000 | 20182966 |
| Saturday, January 1, 2022 | 3345000 | 17562000 |
| Sunday, January 1, 2023 | 2461000 | 25212000 |
Data in motion
In the ever-evolving biotech industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Pharming Group N.V. and Dyne Therapeutics, Inc. from 2014 to 2023.
Pharming Group N.V. has shown a steady increase in its cost of revenue, peaking in 2018 with a 510% rise from 2014. This consistent growth reflects the company's expanding operations and market reach.
Conversely, Dyne Therapeutics, Inc. experienced a dramatic fluctuation. After a significant spike in 2017, costs plummeted by 99% in 2018, indicating a strategic shift or operational restructuring.
These insights highlight the contrasting financial strategies of these biotech firms, offering a window into their operational priorities and market positioning.
AstraZeneca PLC vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Novartis AG vs Dyne Therapeutics, Inc.
Cost of Revenue: Key Insights for Sanofi and Dyne Therapeutics, Inc.
United Therapeutics Corporation vs Dyne Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Xenon Pharmaceuticals Inc.
Cost of Revenue Comparison: Pharming Group N.V. vs PTC Therapeutics, Inc.
Cost of Revenue Trends: Pharming Group N.V. vs HUTCHMED (China) Limited
Cost Insights: Breaking Down Pharming Group N.V. and Galapagos NV's Expenses
Cost Insights: Breaking Down MorphoSys AG and Dyne Therapeutics, Inc.'s Expenses
Cost Insights: Breaking Down Mesoblast Limited and Dyne Therapeutics, Inc.'s Expenses
Cost Insights: Breaking Down Travere Therapeutics, Inc. and Dyne Therapeutics, Inc.'s Expenses
Cost of Revenue Comparison: Dyne Therapeutics, Inc. vs Viridian Therapeutics, Inc.